Literature DB >> 9279286

The emergence of mouse models of atherosclerosis and their relevance to clinical research.

J D Smith1, J L Breslow.   

Abstract

Due to the ability to introduce or mutate genes, the mouse has become the most common experimental animal model for atherosclerosis research. Wildtype mice on a chow diet do not get atherosclerosis. Three ways to induce atherosclerosis in mice are discussed: diet-induced, apoE deficiency-induced, and LDL receptor-deficiency induced. The atherosclerotic lesions in apoE-deficient mice have been well characterized, and they resemble human lesions in their sites of predilection and progression to the fibroproliferative stage. These mouse models of atherosclerosis are being used to identify genes which modify atherosclerosis susceptibility and in the development of antiatherogenic therapies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9279286     DOI: 10.1046/j.1365-2796.1997.00197.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  21 in total

1.  Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis.

Authors:  Xue-Qing Zhang; Orli Even-Or; Xiaoyang Xu; Mariska van Rosmalen; Lucas Lim; Suresh Gadde; Omid C Farokhzad; Edward A Fisher
Journal:  Adv Healthc Mater       Date:  2014-08-22       Impact factor: 9.933

2.  Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development.

Authors:  Cheryl A Conover; Megan A Mason; Laurie K Bale; Sean C Harrington; Mette Nyegaard; Claus Oxvig; Michael T Overgaard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-05-14       Impact factor: 4.733

3.  Microscope-based near-infrared stereo-imaging system for quantifying the motion of the murine epicardial coronary arteries in vivo.

Authors:  David S Long; Hui Zhu; Morton H Friedman
Journal:  J Biomed Opt       Date:  2013-09       Impact factor: 3.170

4.  Effects of mutated pregnancy-associated plasma protein-a on atherosclerotic lesion development in mice.

Authors:  Henning B Boldt; Laurie K Bale; Zachary T Resch; Claus Oxvig; Michael T Overgaard; Cheryl A Conover
Journal:  Endocrinology       Date:  2012-11-16       Impact factor: 4.736

5.  Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor.

Authors:  Debapriya Basu; Yunying Hu; Lesley-Ann Huggins; Adam E Mullick; Mark J Graham; Tomasz Wietecha; Shelley Barnhart; Allison Mogul; Katharina Pfeiffer; Andreas Zirlik; Edward A Fisher; Karin E Bornfeldt; Florian Willecke; Ira J Goldberg
Journal:  Circ Res       Date:  2018-01-10       Impact factor: 17.367

6.  Expression and location of intracellular tissue factor in atherosclerosis stable plaque of ApoE(-/-) mice.

Authors:  Jun Li; Tao Chen; Dingmiao Wang; Yifeng Song; Mei Hong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

Review 7.  Regulation of cell migration in atherosclerosis.

Authors:  R Kraemer
Journal:  Curr Atheroscler Rep       Date:  2000-09       Impact factor: 5.113

8.  Long-term vitamin E supplementation reduces atherosclerosis and mortality in Ldlr-/- mice, but not when fed Western style diet.

Authors:  Mohsen Meydani; Paul Kwan; Michael Band; Ashley Knight; Weimin Guo; Jason Goutis; Jose Ordovas
Journal:  Atherosclerosis       Date:  2014-01-08       Impact factor: 5.162

9.  A model of primary atherosclerosis and post-angioplasty restenosis in mice.

Authors:  Jeremy E Leidenfrost; M Faisal Khan; Kenneth P Boc; Brian R Villa; Emily T Collins; William C Parks; Dana R Abendschein; Eric T Choi
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  Peroxisome proliferator-activated receptor alpha,gamma coagonist LY465608 inhibits macrophage activation and atherosclerosis in apolipoprotein E knockout mice.

Authors:  Steven H Zuckerman; Raymond F Kauffman; Glenn F Evans
Journal:  Lipids       Date:  2002-05       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.